A. S. Nekrasov

A. S. Nekrasov

Auto-generated profile, based on publicly available information

A. S. Nekrasov

Research Institute of the Ochapovsky Regional Clinical Hospital № 1

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
AKA. A. Kuznetsov
A. A. Kuznetsov
Alim NamitokovAlim Namitokov
Alim Namitokov
ASA. V. Sazhneva
A. V. Sazhneva
ANA. S. Nekrasov
A. S. Nekrasov
EKE. D. Kosmacheva
E. D. Kosmacheva
Spontaneous coronary artery dissection is a rare disease that threatens the patient life. Often this pathology complicates the course of pregnancy or the postpartum period. The rare occurrence and difficulties in diagnosis are the reason for the lack of data and the impossibility of developing a single algorithm for diagnosing and treating spontaneous coronary artery dissection.The article provides a brief literature review and a case report of spontaneous coronary artery dissection in the postpartum period, and discusses a number of aspects of treatment tactics.

25 March 2020 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
AGA. A. Grechishkin
A. A. Grechishkin
SMS. V. Maingart
S. V. Maingart
ANA. S. Nekrasov
A. S. Nekrasov
AFA. N. Fedorchenko
A. N. Fedorchenko
VPV. A. Porhanov
V. A. Porhanov
CМC. В. Майнгарт
C. В. Майнгарт
Coronary artery perforation is a rare (0.1–3.0%) but rather severe complication that occurs during the coronary interventions. Treating the perforation caused by the coronary conductor is extremely complicated, as it could be caused quite unexpectedly and may be accompanied by catastrophic consequences if misdirected. Choosing effective treatment techniques is not easy, as evidenced by hospital and remote clinical outcomes with high mortality rates.

4 September 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
SBS. A. Belash
S. A. Belash
KBK. O. Barbukhatti
K. O. Barbukhatti
SSS. S. Shevchenko
S. S. Shevchenko
EYE. P. Yasakova
E. P. Yasakova
ANA. S. Nekrasov
A. S. Nekrasov
VPV. A. Porkhanov
V. A. Porkhanov
Aim. To determine the optimal method for performing coronary artery endarterectomy (СE) based on immediate and long-term outcomes of coronary artery bypass grafting (CABG) in combination with open or closed CE in the left anterior descending artery (LAD).Material and methods. This retrospective study included 103 patients who underwent CABG in combination with closed CE and 204 after open CE in the LAD during the period from 2003 to 2016. In both groups, the patient age was comparable (65 years [56; 69] vs 67 years [58; 72] (p=0,263)). There were more men (88,3% vs 81,4% (p=0,421). The mean follow-up period was 94 months [38; 180]. Long-term outcomes were assessed in 86,4% (n=89) and 83,8% (n=171) of patients from the closed and open CE groups, respectively (p=0,141). Angiographic data were studied in 75,3% and 67,3% of patients, respectively (p=0,441).Results. In the closed and open CE groups, in-hospital mortality was 4,8% and 1,5% (p=0,0012), incidence of perioperative myocardial infarction — 11,6% vs 2,5%, (p<0,001), survival rate after 7,8 years — 81,3±5,1% and 84,4±3,2% (p=0,342), respectively. The patency of arterial shunts was significantly higher in the open CE group — 93,1% vs 80,6% (p=0,004). At the same time, the patency of venous shunts in the long-term period between the groups was comparable — 70,1% vs 73,7% (p=0,314).Conclusion. Open CE in combination with CABG provides better immediate outcomes compared to closed CE. Long-term survival and freedom from angina between the groups were comparable. In the long-term period, the patency of internal thoracic artery after open CE is better than after the closed technique. Open CE is a safe and effective method to achieve complete myocardial revascularization in patients with severe diffuse LAD atherosclerosis.

29 March 2019 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
AGA. A. Grechishkin
A. A. Grechishkin
SMS. V. Mayngart
S. V. Mayngart
ANA. S. Nekrasov
A. S. Nekrasov
AFA. N. Fedorchenko
A. N. Fedorchenko
VPV. A. Porhanov
V. A. Porhanov
Despite the rapid evolution in the development of endovascular surgery, the mortality of patients undergoing percutaneous coronary interventions (PCI) with high risk of severe cardiac complications and critical conditions (cardiogenic shock, cardiac arrest) remains extremely high. The success of PCI directly depends on the ability of the Heart Team to prevent and timely eliminate severe cardiac disorders. Despite the rapid evolution in the development of endovascular surgery, the mortality of patients undergoing percutaneous coronary interventions (PCI) with high risk of severe cardiac complications and critical conditions (cardiogenic shock, cardiac arrest) remains extremely high. The success of PCI directly depends on the ability of the Heart Team to prevent and timely eliminate severe cardiac disorders. Pharmacological therapy is not able to completely resist the development of severe cardiac events during PCI. In such situations the usage of devices for percutaneous mechanical circulation support (PMCS) can make an invaluable help in the treatment of this group of patients. Despite the fact that the PMCS devices are used to stabilize patients with cardiogenic shock and to provide hemodynamic support for high-risk PCI for several decades, the results of their application remain ambiguous. The purpose of this article is to review all existing literature on modern PMCS devices, available data and research results, indications for their use, and operational considerations that can ensure the decision-making process in selecting optimal PMCS devices.